Skip to content
Search

Latest Stories

Submit Guest Post

NHS to launch trial for world’s first norovirus vaccine

Norovirus infects around four million people annually in the UK, leading to 12,000 hospitalisations and about 80 deaths.

The vaccine, based on mRNA technology, aims to prevent the highly contagious virus that causes vomiting and diarrhoea. (Representational image: iStock)
The vaccine, based on mRNA technology, aims to prevent the highly contagious virus that causes vomiting and diarrhoea. (Representational image: iStock)

THE WORLD's first vaccine for norovirus, developed by US company Moderna, will be trialled on NHS patients this winter.

The vaccine, based on mRNA technology, aims to prevent the highly contagious virus that causes vomiting and diarrhoea.


The Times reported that the trial will involve 2,500 participants, mostly elderly patients.

Norovirus infects around four million people annually in the UK, leading to 12,000 hospitalisations and about 80 deaths. There is currently no vaccine for the virus.

Moderna’s new vaccine, mRNA-1403, has shown a strong immune response to multiple strains of norovirus in earlier trials. The vaccine’s development is part of a ten-year partnership between the UK government and Moderna, which aims to position the UK as a leader in life sciences.

The trial will recruit participants from 27 NHS hospitals and clinics across England, Scotland, and Wales.

Mobile clinics may visit care homes and community sites to include elderly individuals. Half of the participants will receive the vaccine, while the other half will receive a placebo.

The trial will track the participants for around 25 months to assess the vaccine’s effectiveness, with researchers aiming for a 65 per cent or higher efficacy rate. If successful, the vaccine could be available on the NHS by 2026, The Times reported.

Health Secretary Wes Streeting highlighted the burden norovirus places on the NHS, costing taxpayers around £100 million annually. He said the trial could shift the focus of the health system from treating illness to prevention.

Experts are hopeful that the vaccine will eventually be used seasonally, similar to the flu jab, or potentially offer lifelong immunity, The Times reported.

The trial is led by Dr Patrick Moore, a GP in Dorset, with participation from other countries including the US, Canada, and Japan.

Researchers hope the vaccine will reduce the impact of norovirus on healthcare systems and workplaces.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Sheikh-Hasina-return

A police officer moves past a burning vehicle that was set afire by demonstrators following a clash between the police and garment workers protesting for higher wages, in Gazipur, Bangladesh, November 18, 2026.

REUTERS/Stringer

Bangladesh steps up security amid violence over Sheikh Hasina’s planned return

Highlights

  • Hasina has requested a new passport and identity card ahead of a planned return in December.
  • Police have reported dozens of bomb blasts and vehicle fires in at least 28 districts over 10 days.
  • At least 71 members of banned organisations have been arrested in Dhaka in the past 24 hours.
  • A bus company worker was burnt to death after two buses were set on fire in Pirojpur.

BANGLADESH stepped up security and deployed hundreds of paramilitary troops nationwide on Wednesday (18) as the planned return of former prime minister Sheikh Hasina has sparked clashes, bomb blasts and arson attacks blamed on supporters of her banned party.

Keep ReadingShow less